Literature DB >> 24114599

Peripheral T-cell lymphoma in a patient with Crohn's disease.

Srilakshmi Sudha Kollepara1, Mohammad Muhsin Chisti, Seerin Viviane Shatavi, Ishmael A Jaiyesimi.   

Abstract

A 46-year-old man with a long-standing history of Crohn's disease who was treated with multiple therapies over a period of 9 years presented with oral lesions which on biopsy demonstrated peripheral T-cell lymphoma. Initially, the development of T-cell lymphoma was presumed to be secondary to prolonged immunosuppression but it did not respond to withholding immunosuppressive therapy. On treatment with CHOP (cyclophosphamide, hydroxydaunorubicin, oncovin and prednisone) chemotherapy, complete remission was achieved. Although development of malignancies in the immune-suppressed patient with Crohn's disease has been previously described but we present a rare case of T-cell lymphoma in a similar patient, which has not been reported before.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24114599      PMCID: PMC3822147          DOI: 10.1136/bcr-2013-200606

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease.

Authors:  Meenakshi Bewtra; James D Lewis
Journal:  Expert Rev Clin Immunol       Date:  2010-07       Impact factor: 4.473

2.  Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry.

Authors:  S Caillard; C Lelong; F Pessione; B Moulin
Journal:  Am J Transplant       Date:  2006-11       Impact factor: 8.086

3.  Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.

Authors:  A Kandiel; A G Fraser; B I Korelitz; C Brensinger; J D Lewis
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

Review 4.  The risk of cancer in patients with Crohn's disease.

Authors:  Alexander C von Roon; George Reese; Julian Teare; Vasilis Constantinides; Ara W Darzi; Paris P Tekkis
Journal:  Dis Colon Rectum       Date:  2007-06       Impact factor: 4.585

Review 5.  Lymphoma in inflammatory bowel disease and treatment decisions.

Authors:  Meenakshi Bewtra
Journal:  Am J Gastroenterol       Date:  2012-07       Impact factor: 10.864

6.  Inflammatory bowel disease is not associated with an increased risk of lymphoma.

Authors:  J D Lewis; W B Bilker; C Brensinger; J J Deren; D J Vaughn; B L Strom
Journal:  Gastroenterology       Date:  2001-11       Impact factor: 22.682

7.  T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.

Authors:  Parakkal Deepak; Humberto Sifuentes; Muhammed Sherid; Derrick Stobaugh; Yama Sadozai; Eli Daniel Ehrenpreis
Journal:  Am J Gastroenterol       Date:  2012-10-02       Impact factor: 10.864

8.  A case of rapid growing colonic NK/T cell lymphoma complicated by Crohn's disease.

Authors:  Shumei Zheng; Hui Xu; Qin Ouyang; Linyun Xue; Yong Zhang; Dejun Cui
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

9.  Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County.

Authors:  T Ljung; P Karlén; D Schmidt; P M Hellström; A Lapidus; I Janczewska; U Sjöqvist; R Löfberg
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

10.  Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis.

Authors:  Corey A Siegel; Sadie M Marden; Sarah M Persing; Robin J Larson; Bruce E Sands
Journal:  Clin Gastroenterol Hepatol       Date:  2009-01-24       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.